|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
C67.5 |
Malignant neoplasm of bladder neck
|
C675 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 54.52%
|
26.04%
|
8.41%
|
3.99%
|
2.04%
|
1.81%
|
1.05%
|
0.65%
|
0.53%
|
0.29%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C67.5*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
J3010
|
FENTANYL CITRATE INJECTION |
2,157
|
3,207
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
1,904
|
47,866
|
|
J2405
|
ONDANSETRON HCL INJECTION |
1,901
|
8,341
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
1,526
|
1,767
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
1,496
|
1,506
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
1,429
|
1,431
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
1,320
|
5,309
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
1,253
|
8,361
|
|
80053
|
COMPREHEN METABOLIC PANEL |
1,236
|
1,236
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,168
|
1,178
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
1,093
|
3,340
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
1,077
|
1,549
|
|
J7120
|
RINGERS LACTATE INFUSION |
931
|
1,193
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
785
|
5,170
|
|
52235
|
CYSTOSCOPY AND TREATMENT |
771
|
771
|
|
80048
|
METABOLIC PANEL TOTAL CA |
728
|
728
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
666
|
53,025
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
645
|
1,312
|
|
52234
|
CYSTOSCOPY AND TREATMENT |
598
|
598
|
|
51720
|
TREATMENT OF BLADDER LESION |
579
|
579
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C67.5 related to the following DRG Codes:
656-658
686-688
|
